Impact of the FDA removal of black box warnings

 In this episode, Dr. Allyson Brooks, the Ginny Ueberroth Executive Medical Director Endowed Chair of the Hoag Women’s Health Institute, discusses how Hoag is transforming menopause care through multidisciplinary collaboration, education, and community engagement. She shares how the FDA’s recent hormone therapy update and women’s growing advocacy are reshaping the future of midlife health.